Table 1. Characteristics of patients with myelodysplastic syndrome.
| Characteristic | MDS (N = 54) |
|---|---|
| Sex (man:woman) | 37:17 |
| Age (median, range) | 56 (22−82) |
| Blood routine (median, range) | |
| Hemoglobin (g/dL) | 8.0 (3.8−14.8) |
| White blood cell count (× 109/L) | 2,570 (630−9,520) |
| Absolute neutrophil count (× 109/L) | 1,159 (140−4,737) |
| Platelet count (× 109/L) | 97 (9−321) |
| Blast (%) | 0 (0−10) |
| Bone marrow blast (%) | 2.95 (0−16.5) |
| Subtypes by 2008 WHO criteria (N, %) | |
| RCUD | 16 (29.6) |
| RARS | 3 (5.6) |
| RCMD | 7 (13.0) |
| RAEB | 26 (48.2) |
| MDS-U | 2 (3.7) |
| Subtypes by IPSS (N, %) | |
| Low | 4 (7.4) |
| Intermediate-1 | 27 (50.0) |
| Intermediate-2 | 13 (24.1) |
| High | 10 (18.5) |
Abbreviations: IPSS, International Prognostic Scoring System; RCUD, refractory cytopenia of unilineage dysplasia; RARS, refractory anemia with ringed sideroblasts; RCMD, refractory cytopenia of multilineage dysplasia; RAEB, refractory anemia of excess blasts; MDS-U, unspecified MDS.